Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Houston, TX, USA.
Medical Affairs, US, Astellas Pharma Global Development, Inc., Northbrook, IL, USA.
Drugs Aging. 2021 Apr;38(4):311-326. doi: 10.1007/s40266-021-00833-x. Epub 2021 Mar 8.
Overactive bladder (OAB), the primary cause of urinary incontinence in nursing homes, is commonly treated with anticholinergic medications; however, the elderly population is vulnerable to the adverse effects associated with anticholinergic burden. Given the relatively high prevalence of OAB among nursing home residents, it is important to understand the magnitude of anticholinergic burden in this population.
The objectives of this study were to (1) examine the prevalence of cumulative anticholinergic burden among long-stay nursing home (LSNH) residents with OAB; and (2) identify the factors associated with varying levels of cumulative anticholinergic burden.
This was a retrospective, cohort study using Minimum Data Set-linked Medicare claims data. Anticholinergic burden was determined based on the Anticholinergic Cognitive Burden scale and patient-specific dosing using defined daily dose. The Andersen Behavioral Model framework was used to identify the predisposing, enabling, and need factors associated with levels of anticholinergic burden. Multivariable logistic regression models were developed to determine the factors associated with levels of anticholinergic burden.
A total of 123,308 LSNH residents with OAB were identified; 87.2% had some degree of anticholinergic burden and 27.3% had high cumulative burden. Multiple factors were associated with higher levels of burden, including younger age, female sex, and non-Hispanic White ethnicity (predisposing factors); dual eligibility, Southern geographic region, and rural residence (enabling factors); and a number of comorbidities and concomitant medications (need factors).
This study revealed a high level of anticholinergic burden among LSNH residents. Multiple factors were associated with a high level of burden. There is a need to optimize the use of anticholinergics due to their significant safety concerns in the LSNH setting.
在养老院中,膀胱过度活动症(OAB)是导致尿失禁的主要原因,通常采用抗胆碱能药物进行治疗;然而,老年人易受到抗胆碱能负担相关不良反应的影响。鉴于养老院居民中 OAB 的患病率相对较高,了解该人群中抗胆碱能负担的程度非常重要。
本研究旨在:(1)评估患有 OAB 的长期居住养老院(LSNH)居民累积抗胆碱能负担的发生率;(2)确定与累积抗胆碱能负担程度相关的因素。
这是一项使用最小数据集链接医疗保险索赔数据的回顾性队列研究。抗胆碱能负担根据抗胆碱能认知负担量表和基于定义日剂量的患者特定剂量来确定。采用安德森行为模型框架确定与抗胆碱能负担程度相关的倾向因素、促成因素和需求因素。采用多变量逻辑回归模型确定与抗胆碱能负担程度相关的因素。
共确定了 123308 例患有 OAB 的 LSNH 居民;87.2%存在一定程度的抗胆碱能负担,27.3%存在高累积负担。多个因素与较高水平的负担相关,包括年龄较小、女性和非西班牙裔白人种族(倾向因素);双重资格、南部地理区域和农村居住(促成因素);以及多种合并症和伴随药物(需求因素)。
本研究揭示了 LSNH 居民中存在较高水平的抗胆碱能负担。多个因素与高负担水平相关。由于抗胆碱能药物在 LSNH 环境中存在显著的安全性问题,因此需要优化其使用。